stars 1 stars 2 stars 3

Colbar develops and manufactures a range of innovative tissue engineering products based on its patented cross-linked collagen technology. Using this breakthrough technology, Colbar can develop products with longevity and degradation rates programmed to meet specific clinical needs. Colbar's products closely mimic natural human cross-linked collagen, a key biological polymer that provides structure and strength, and supports the function of most human tissues and organs. Colbar has received funding from several venture capital firms: Vitalife, Genesis Partners, Biomedical Investments, Pitango Venture Capital and Evergreen Venture Capital.

ColBar LifeScience Ltd. Questions

The ColBar LifeScience Ltd. annual revenue was $7.2 million in 2026.

5 people are employed at ColBar LifeScience Ltd..

The NAICS codes for ColBar LifeScience Ltd. are [3254, 32541, 325, 53, 532, 32].

The SIC codes for ColBar LifeScience Ltd. are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users